| Reference | Name | Unity | Provider | Aplication | Clonality | Host | Reactivity | Price | Tech.Sheet |
|---|---|---|---|---|---|---|---|---|---|
| Ab00122-10.0-BT | Anti-CD3 epsilon [OKT-3 (muromonab)] | 1 mg | Absolute Antibody | FC | Human | Request Quotation | Request | ||
| Ab00133-2.0 | Anti-EGFR [528] | 200 ug | Absolute Antibody | IF; IHC-P; IP; NTRL; WB; FC | Human | Request Quotation | Request | ||
| Ab00147-6.1-VPT | Anti-IL-4 [11B11] | 10 mg | Absolute Antibody | ELISA; FC; in vivo; IHC | Mouse | Request Quotation | Request | ||
| Ab00132-1.1 | Anti-Der p 1, Der f 1 [4C1] | 200 ug | Absolute Antibody | ELISA | House Dust Mite | Request Quotation | Request | ||
| Ab00138-23.0-BT | Anti-Insulin receptor alpha [83-7] | 1 mg | Absolute Antibody | ELISA; IHC-P; IP | Human | Request Quotation | Request | ||
| Ab00135-8.1 | Anti-Beta-galactosidase [13R4] | 200 ug | Absolute Antibody | WB; FC; negative control | E. Coli | Request Quotation | Request | ||
| Ab00114-10.0-BS | Anti-HLA Class 1 [W6/32] | 1 mg | Absolute Antibody | FC; ELISA; IF; IP; IHC | Human | Request Quotation | Request | ||
| Ab04134-10.3 | Anti-ALCAM [035-234] | 100 ug | Absolute Antibody | FACS; ADCC | Human | Request Quotation | Request | ||
| Ab02575-4.3-BT | Anti-a3 domain of H-2Kd MHC class I [SF1-1.1.1] | 1 mg | Absolute Antibody | WB; FC; IHC; IP; IF | Mouse | Request Quotation | Request | ||
| Ab00124-23.0-BT | Anti-CD52 [Alemtuzumab (Campath-1H)] | 1 mg | Absolute Antibody | Cytotoxicity Assay; ELISA; IHC-Fr; IHC-P; in vivo; | Human; Rhesus Monkey; Cynomolgus Monkey | Request Quotation | Request | ||
| Ab00909-10.3 | Anti-acetylcholine receptor [mAb198] | 200 ug | Absolute Antibody | Crystallisation; WB; ELISA; IP; IHC; deplete | Human | Request Quotation | Request | ||
| Ab00135-23.0-BT | Anti-Beta-galactosidase [13R4] | 1 mg | Absolute Antibody | WB; FC; negative control | E. Coli | Request Quotation | Request | ||
| Ab00135-6.1-BT | Anti-Beta-galactosidase [13R4] | 1 mg | Absolute Antibody | WB; FC; negative control | E. Coli | Request Quotation | Request | ||
| Ab00147-23.0 | Anti-IL-4 [11B11] | 200 ug | Absolute Antibody | ELISA; FC; in vivo; IHC | Mouse | Request Quotation | Request | ||
| Ab00138-23.0 | Anti-Insulin receptor alpha [83-7] | 200 ug | Absolute Antibody | ELISA; IHC-P; IP | Human | Request Quotation | Request | ||
| Ab01654-10.3-BT | Anti-alpha catenin [1G5] | 1 mg | Absolute Antibody | WB; IF; IP | Human; Mouse | Request Quotation | Request | ||
| Ab00146-23.0-BT | Anti-TNF alpha [cA2 (Infliximab)] | 1 mg | Absolute Antibody | ELISA; in vivo; FC | Human | Request Quotation | Request | ||
| Ab00111-1.1-VPT | Anti-CD200R [OX131] | 10 mg | Absolute Antibody | FC | Mouse | Request Quotation | Request | ||
| Ab00129-36.0 | Anti-CD40 [G28.5] | 200 ug | Absolute Antibody | FC; IP; IHC; activate | Human | Request Quotation | Request | ||
| Ab00129-15.0-BT | Anti-CD40 [G28.5] | 500 ug | Absolute Antibody | FC; IP; IHC; activate | Human | Request Quotation | Request | ||
| Ab03397-10.3-BT | Anti-alpha-SMA [8E5D12A9] | 1 mg | Absolute Antibody | IHC; WB; ELISA | Human | Request Quotation | Request | ||
| Ab00122-2.0-BT | Anti-CD3 epsilon [OKT-3 (muromonab)] | 1 mg | Absolute Antibody | FC | Human | Request Quotation | Request | ||
| Ab00120-1.1-BT | Anti-Bax (active monomer) [6A7] | 1 mg | Absolute Antibody | IHC; IP; WB | Human; Mouse; Rat | Request Quotation | Request | ||
| Ab00111-1.1-VPS | Anti-CD200R [OX131] | 25 mg | Absolute Antibody | FC | Mouse | Request Quotation | Request | ||
| Ab00134-6.1-VPB | Anti-EGFR [7A7] | 100 mg | Absolute Antibody | IHC; in vivo; FC; IF | Human; Mouse | Request Quotation | Request | ||
| Ab02895-10.3 | Anti-AC toxin [2F5] | 200 ug | Absolute Antibody | WB; ELISA | Bordetella pertussis | Request Quotation | Request | ||
| Ab00120-1.1 | Anti-Bax (active monomer) [6A7] | 200 ug | Absolute Antibody | IHC; IP; WB | Human; Mouse; Rat | Request Quotation | Request | ||
| Ab00147-6.1-VPS | Anti-IL-4 [11B11] | 25 mg | Absolute Antibody | ELISA; FC; in vivo; IHC | Mouse | Request Quotation | Request | ||
| Ab00144-1.1-BT | Anti-Polyglutamine repeats [3B5H10] | 1 mg | Absolute Antibody | IF; IP | Human | Request Quotation | Request | ||
| Ab00147-6.1-VPB | Anti-IL-4 [11B11] | 100 mg | Absolute Antibody | ELISA; FC; in vivo; IHC | Mouse | Request Quotation | Request | ||
| Ab00128-1.1-BT | Anti-CD38 [HB7] | 1 mg | Absolute Antibody | FC; IP | Human | Request Quotation | Request | ||
| Ab00129-26.0 | Anti-CD40 [G28.5] | 200 ug | Absolute Antibody | FC; IP; IHC; activate | Human | Request Quotation | Request | ||
| Ab00110-2.0-VXB | Anti-CD134 [OX86] | 100 mg | Absolute Antibody | FC; agonist; IF; ELISA | Mouse | Request Quotation | Request | ||
| Ab01118-2.3-BT | Anti-Adenylate Cyclase Toxin [9D4] | 1 mg | Absolute Antibody | FC; ELISA; WB; IP; neutralising/inihibition assays | Bordetella pertussis | Request Quotation | Request | ||
| Ab00129-1.1 | Anti-CD40 [G28.5] | 200 ug | Absolute Antibody | FC; IP; IHC; activate | Human | Request Quotation | Request | ||
| Ab03276-10.3-BT | Anti-Alpha Dystroglycan [1G12] | 1 mg | Absolute Antibody | ELISA; WB; FC; IF | Human | Request Quotation | Request | ||
| Ab00126-35.0-BT | Anti-CD20 [10F381 (rituximab)] | 1 mg | Absolute Antibody | FC | Human; Rhesus Monkey; Cynomolgus Monkey | Request Quotation | Request | ||
| Ab00135-23.0 | Anti-Beta-galactosidase [13R4] | 200 ug | Absolute Antibody | WB; FC; negative control | E. Coli | Request Quotation | Request | ||
| Ab00135-9.1 | Anti-Beta-galactosidase [13R4] | 200 ug | Absolute Antibody | WB; FC; negative control | E. Coli | Request Quotation | Request | ||
| Ab00140-1.1-BT | Anti-IL-18 [125-2H] | 1 mg | Absolute Antibody | ELISA; IF; IP; NTRL | Human | Request Quotation | Request | ||
| Ab00782-10.6-BT | Anti-A33 [huA33] | 1 mg | Absolute Antibody | deplete; ELISA; IF; IHC | Human | Request Quotation | Request | ||
| Ab00129-35.0 | Anti-CD40 [G28.5] | 200 ug | Absolute Antibody | FC; IP; IHC; activate | Human | Request Quotation | Request | ||
| Ab00117-1.1 | Anti-Factor H [OX23] | 200 ug | Absolute Antibody | ELISA; WB; IP; block | Human; Primate; Mouse | Request Quotation | Request | ||
| Ab00135-4.0 | Anti-Beta-galactosidase [13R4] | 200 ug | Absolute Antibody | WB; FC; negative control | E. Coli | Request Quotation | Request | ||
| Ab00387-1.4 | Anti-A2A-Adenosine Receptor [Ig2838] | 200 ug | Absolute Antibody | ELISA; Blocking | Human | Request Quotation | Request | ||
| Ab00129-37.0 | Anti-CD40 [G28.5] | 200 ug | Absolute Antibody | FC; IP; IHC; activate | Human | Request Quotation | Request | ||
| Ab00143-1.1-BT | Anti-P-glycoprotein [MRK16] | 500 ug | Absolute Antibody | FC; IF; IP | Human | Request Quotation | Request | ||
| Ab00135-22.0-BT | Anti-Beta-galactosidase [13R4] | 1 mg | Absolute Antibody | WB; FC; negative control | E. Coli | Request Quotation | Request | ||
| Ab00116-10.0-BS | Anti-Polyethylene Glycol [E11] | 1 mg | Absolute Antibody | ELISA; WB; FC | n/a | Request Quotation | Request | ||
| Ab00142-2.0 | Anti-p53 [PAb421] | 200 ug | Absolute Antibody | ELISA; IF; IHC-Fr; IHC -P; in vivo; IP; WB | Human; Monkey; Mouse; Rabbit, Rat | Request Quotation | Request |